Previous 10 | Next 10 |
After trading down from $2.86/share to $.75/share so far this year, Agile's share price is reflecting worse-case scenario. Despite the market sell-off, Agile's business is actually ramping up. Given Agile's revenue projections and trend, the stock price should be trading closer to...
The following slide deck was published by Agile Therapeutics, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Agile Therapeutics, Inc. 2021 Q3 - Results - Earnings Call Presentation
Agile Therapeutics, Inc. (AGRX) Q3 2021 Results Conference Call November 02 2021 04:30 PM ET Company Participants Matthew Riley - Head of Investor Relations and Corporate Communications Alfred Altomari - Chairman and Chief Executive Officer Dennis Reilly - Chief Financial Officer Conference C...
Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla Cycles Dispensed Twirla Refill Rates Continue to Grow by 86% in Third Quarter 2021 Company Advances Programs Focused on Increasing Demand for Twirla Management to Host Co...
PRINCETON, N.J., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report third quarter 2021 financial results after the market close on Tuesday, November 2, 2021 as follows: Investors inte...
Agile Therapeutics continues to trade under intense selling pressure. This selling amplified after the company announced a sizeable offering. My "house money" position has been mostly sitting on the sidelines waiting for a capitulation and "max pain" event. I discuss my strategy for t...
3 Top Penny Stocks That Could Be Worth Adding to Your Watchlist Finding the best penny stocks for your watchlist is all about understanding where to look. While there are hundreds of penny stocks to choose from, not all of them will offer the same value point as others. So, if you...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! I hope the weekend served you well because we’ve got pre-market stock movers to start off Monday with! Source: Eric Urquhart/Shutterstock.com Pharmaceutical companies are dominating toda...
4 Reddit Biotech Penny Stocks to Watch in October 2021 Over the past year, biotech penny stocks have become favorites among investors. And, there are a few obvious reasons for that. First off, if we look at the pandemic, we see that it sparked a major focus on the biotech industry and c...
PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today applauded House Congressional Committee leaders in urging the Secretaries of U.S. Departments of Health and Human Services (HHS), Treasury, and La...
News, Short Squeeze, Breakout and More Instantly...
Agile Therapeutics Inc. Company Name:
AGRX Stock Symbol:
NASDAQ Market:
Agile Therapeutics Inc. Website:
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare com...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2...